Claro Advisors LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Claro Advisors LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the fourth quarter, Holdings Channel reports. The fund owned 1,250 shares of the medical equipment provider’s stock after purchasing an additional 37 shares during the period. Claro Advisors LLC’s holdings in Intuitive Surgical were worth $652,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $38,000. DT Investment Partners LLC increased its stake in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the last quarter. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter worth $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Down 1.4 %

Shares of NASDAQ:ISRG opened at $539.75 on Tuesday. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $556.23. The stock’s fifty day simple moving average is $536.58 and its 200-day simple moving average is $495.83. The company has a market capitalization of $192.25 billion, a P/E ratio of 86.78, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.